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ABSTRACT  
Background: It has been suggested that inaccuracies in cancer registries are distorting UK 
survival statistics. This study compared the Northern Ireland Cancer Registry (NICR) database 
of living patients, with independent data held by Northern Ireland’s General Practitioners (GPs) 
to compare and validate the recorded diagnoses and dates held by the registry. 
 
Methods: All 387 GP practice managers were invited to participate. 100 practices (25.84%) 
responded. Comparisons were made for 17,102 patients, equivalent to 29.08% of the living 
patients (58,798) extracted from the NICR between 1993-2010.  
 
Results:  There were no significant differences (p>0.05) between the responding and non 
responding GP patient profiles for age, marital status or deprivation score, however the 
responding GPs included more female patients (p=0.02).  NICR data accuracy was high, 0.08% 
of GP cancer patients (n=15) were not included in registry records and 0.02% (n:2) had a 
diagnosis date which varied more than 2 weeks from GP records (3 weeks and 5 months). The 
NICR had recorded 2 different tumour types and 3 different tumour statuses (benign v 
malignant) to the GPs.  
 
Conclusion: This comparison demonstrates a high level of accuracy within the NICR and that 
the survival statistics based on this data can be relied upon. 
 
Key words: Validation, Cancer Registry completeness, Survival, unique patient identifier.  
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INTRODUCTION 
Cancer registries are a fundamental component of cancer control programmes [1], with collated 
information used in the development, provision and evaluation of cancer services as well as 
public health decision making.  The primary aim of cancer registration is to collect data using 
a standardised method to provide timely, high quality data which is nationally and 
internationally comparable on all incident cancer diagnoses within a well-defined population 
over time [2]. 
 
The Northern Ireland Cancer Registry (NICR) holds data on all cancers diagnosed in the 
population since 1993. There are three main sources of data utilised by the NICR; (i) 
histopathology and cytopathology, (ii) the Patient Administration System (PAS) currently used 
by all hospitals in Northern Ireland, which provides demographic information on patients and 
cancer diagnoses (ICD-10 codes) [3] and (iii) death certification. Between the year 1993 and 
2010 histopathology, cytopathology and PAS combined were used to diagnose 98.97% of 
cancer cases, Death Certificate Initiated registrations were 3.57% out of which only 1.02% of 
diagnoses in these years were Death Certificate Only (DCO) notifications.  Diagnoses are 
verified and confirmed by skilled Tumour Verification Officers (TVOs) who regularly 
scrutinise hospital records and histopathology text reports, whilst adhering to standardised 
international procedures [4] . The TVOs also have access to electronic data sources including 
the Clinical Oncology Information System (COIS) which contains annotated clinical oncology 
notes and the Cancer Patient Pathway System (CaPPs) [5]; a system which manages 
multidisciplinary cancer meetings. 
 
The completeness and accuracy of the data held within cancer registries has recently been 
questioned [6,7], although suggestions for how to assess the completeness of registry data go 
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back as far as 1980 [8] . Beral and Peto [6] have suggested that as cancer registration is not 
compulsory within the United Kingdom (UK), unlike Scandinavian countries, [9,10] UK 
datasets are “somewhat incomplete”. They have speculated that UK survival statistics are 
distorted downwards due to the number of unregistered survivors, who will only be included 
on the registry upon death. These DCO registrations however, are excluded from survival 
analysis. Survival rates for many cancers are lower in the UK, compared to other countries 
within the western world [10,11] and it has been hypothesised that this may be due to 
unregistered cancer survivors or recurrences being mistakenly recorded as initial diagnoses.  
 
Under the Quality and Outcome Framework (QOF); General Medical Services Contract (2004) 
[12], GPs are financially incentivised to maintain a high quality up-to-date record of patients 
with chronic conditions, including cancer. As well as receiving discharge summaries, 
outpatient letters and pathology and imaging reports [7], GPs also have direct contact with 
patients and have access to the patients’ detailed medical history. Consequently, they are an 
excellent data repository to use for the comparison and validation of the NICR data. This study 
aimed to assess the completeness and accuracy of the NICR database for surviving patients 
registered between 1993 and 2010, with cancer patient records held by Northern Ireland’s 
General Practitioners (GPs).  
 
METHODS 
A list of living patients, who received a malignant cancer diagnosis C00-C97 (WHO. 1992) 
between 1993 and 2010, was extracted from the NICR database and catalogued onto individual 
GP practice lists. Individuals, for whom a GP practice could not be assigned, were excluded. 
The GP patient lists were then encrypted and password protected.  GP practice managers were 
contacted via email asking would they be willing to take part in the validation study. Practices 
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that consented were then forwarded two separate emails, one containing the encrypted 
spreadsheet relevant to their practice and the other the password. Practices were asked to 
compare the NICR list with their own practice list and to highlight differences between the two 
lists with regard to tumour type and stage, tumour site, date of diagnosis, changes to name and 
address and anything else which they felt was noteworthy. A variation of up to 2 weeks on 
either side of the diagnosis date was considered to be accurate. GP practices were also invited 
to notify the NICR of any cancer patients on their practice list but not on the NICR list.  
 
Statistical Analysis 
Chi square tests were used to make comparisons between responding and non responding GP 
practice patient profiles for gender, marital status, deprivation scores and tumour type (C00-
C97) which were grouped together by site. An independent t-test was carried out to compare 
mean age of the individuals in the two groups.  The alpha level was established as p ≤ 0.05; 
values are reported as mean ± SD. 
 
RESULTS 
387 GP practice managers were contacted, out of which 100 practices (25.84%) responded. 
Comparisons were made for 17,102 patients, equivalent to 29.08% of the NICR cohort (58,798 
patients). 5,373 patients were excluded as the NICR had no record of their GP. There were no 
significant differences (p>0.05) between the responding and non-responding GP patients for 
age, marital status and deprivation score (refer to table 1). No significant difference (p>0.05), 
between the two groups for tumour type was detected (not tabulated). There were more female 
cancer patients among the responding GPs (p=0.02) than the non-responding GPs. There was 
no significant difference (p>0.05) in the size of GP practices between the responders and non-
responders. 
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Table 2 presents the differences that were documented by the GP practices when comparing 
their lists to the NICR list. Out of 17,102 individuals compared, there was a variation on 2 
patient tumour types and 3 patient designations as benign or malignant. It was later confirmed 
that the GPs’ data with regard to status were correct and in each case the registry was updated 
accordingly.  Date of diagnosis differed for 2 records, one record had a variation of 3 weeks 
and the other of 5 months. There were 15 individuals on the GP lists who were not included on 
the NICR.  
 
2 of the 15 individuals lived outside of Northern Ireland when they were diagnosed and 
therefore would not normally be registered. A further 7 were resident in border counties and 
may have been diagnosed in the Republic of Ireland. COIS held data for 2 individuals but they 
had not been registered with the NICR. The NICR database was subsequently updated. The 
remaining 4 GP cases could not be verified and follow-up with the GP practices was 
unsuccessful.  
 
DISCUSSION 
This study compared two independent sources for 17,102 cancer patients and found a registry 
completeness of 99.9%.  The researchers are confident in the representativeness of the sample 
as differences (p > 0.05) between responders and non-responders were not significant, except    
for patient gender. Although the feedback received was comprehensive indicating a sufficient 
time was spent comparing the lists, it must be taken into consideration, that some responding 
GPs may not have provided thorough comparisons between their data and that of the NICR. 
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The 4 individuals on the GP lists but not on the NICR database were diagnosed in different 
years, with different cancers and at different sites. Consequently, this small number of 
unregistered cancers would not materially influence the survival statistics of any particular 
cancer or year within Northern Ireland.  
 
There were only 2 differences found in the recorded date of diagnosis between the NICR 
sample and the GP responses (a 3 weeks difference for a basal cell carcinoma and a 5 months 
difference for an infiltrating duct and lobular carcinoma). As the NICR require histopathology 
to confirm a diagnosis and GPs do not, it is reasonable to allow for a fortnight’s discrepancy 
on either side of the NICR recorded diagnosis date. It can take up to 2 weeks for confirmation 
of diagnosis via histopathology, whereas GPs quite often record a diagnosis date earlier than 
the confirmed diagnosis date. However, in this study, the GP date of diagnosis was after the 
date recorded by the NICR, assuming that the NICR date of diagnosis is correct, there may 
have been a delay with the clinician informing the GPs.  Although not conclusive, the results 
of this study could be taken to indicate that the date of diagnosis held within the NICR is the 
date of first diagnosis and not a recurrence. 
 
Berkel [13] also conducted a similar study in the Netherlands with 11% GP participation and 
found that 15.4% of tumours recorded by the GPs were not on the cancer registry. In this study, 
only 0.1% of tumours on the GP records were not recorded by the NICR. The NICR also 
performed a similar (unpublished) study in 2004, which had a higher response rate (57%). This 
higher response was possibly due to the introduction at that time, of the Quality of Outcome 
Framework for GPs [12] and so the study was a means for GPs to ensure completeness of their 
own records as well as vice versa. In 2004, the GPs identified 2% of the cohort as having a 
different surname than the NICR records, this compares to 0.1% identified in 2010. 3 patients 
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were incorrectly categorised in 2004 by the NICR due to the same names being in the same 
household, e.g. a father/son mix-up, however in 2010 only one such error occurred. A high 
percentage (15%) of addresses required updating in 2004, compared to 0.45% in the current 
study. The high percentage of addresses which were amended in 2004, prompted the 
introduction of a successful scheme linking the NICR with GP patient registration, in order to 
regularly update patient demographic details. This link allowed for the follow-up of patients 
and also aided in participation in research studies such as in International Cancer Benchmark 
Partnership [10].  A recent publication [14] has indicated that 53 of the European General 
Cancer Registries claim to have ≥95% completeness (self-assessed). However, the authors state 
that registries that did not rely on quantitative measures, such as the method of this study, were 
probably overly optimistic.  
 
The improvements in the data’s accuracy between 2004 and 2010 may be to some extent due 
to the introduction of the NHS unique identifier at the end of 2008. The unique identifier 
facilitates automatic matching of datasets thereby reducing the likelihood of missed changes to 
surnames or addresses and reduces the mix-ups between patients such as a father/son.  It also 
enables the cancer registry to assess demographics thereby further improving the data held 
within the registry. 
 
This study highlights the accuracy of the incidence records within the NICR as there were only 
15 individuals included on GP lists which were not on the NICR and out of these 15, only 4 
individuals could not be traced on any records.  It is possible however, that these 4 individuals 
will be detected by the NICR through future death registrations. The low proportion of DCI 
(3.57%) and low DCO (1.02%) is also an indication of high data completeness within the 
NICR. 
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The results from this study disagree with the hypothesis that survival rates in Northern Ireland 
are underestimated due to underreporting of cancer survivors [6]. It can be concluded that the 
NICR holds an accurate database of living patients which can be relied upon for international 
comparisons regarding incidence and survival. Similar evidence for valid survival estimates in 
the UK has been presented by Woods [15] and Coleman[16], using a different methodology. 
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Table 1: A comparison of cancer patients from responding and non responding GPs 
    
  
 Non-responding 
GPs Responding GPs         P value 
GP Practices in border areas 13 14 0.65 
Total patients registered 58798 17102  
Total cases  65758 
 
19072  
Male (%) 44.2 42.8  
Female (%) 55.8 57.2  
Age (years) 67.89 ± 15.52 66.79 ± 15.52 0.95 
Patient marital status (%) 
 
 
  
Married  43.3 43.3  
Single  8.3 8.6  
Couple  0.8 0.9  
Widowed  5.4 4.9  
Unknown  42.2 42.2  
Patient deprivation Score (%)*    
Quintile 1 
22.1 
 
21.3  
Quintile 2 19.6 19.6  
Quintile 3 19.6 20.1  
Quintile 4 20.1 19.9  
Quintile 5 18 18.4  
Unknown 0.7 0.8   
* Quintile 1 is the least deprived and quintile 5 is the most deprived.  
    
 
  
0.02 
0.19 
0.20 
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Table 2: Differences detected between the GP register of cancer    
patients and NICR database (n:17102)   
Differences     
Number of 
individual
s 
% of 
cohort 
(n17102
) 
Change of address  77 0.45 
Different surnames  17 0.10 
Incorrectly identified due to same name in household 
(Father/son) 1 0.005 
Changed GP practice  168 0.98 
GP different date of diagnosis  2 0.01 
GP different tumour on record  2 0.01 
GP different tumour status (benign/malignant) 3 0.02 
GP no record of tumour  17 0.10 
GP recorded death before 31/12/2010 (NICR unware) 16 0.09 
Not included on GP list*  110 0.64 
Not on NICR records    15 0.08 
*GPs indicated patients that were included on their list but not on the NICR 
list.  
 The NICR had a record of these patients, however they did not have the 
patients'  
GP contact details, therefore these individuals were excluded from the study.  
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